Aflac Expands Digital Reach via Ethos Tie-Up in Supplemental Health

19.12.25 17:36 Uhr

Werte in diesem Artikel
Aktien

94,62 EUR 0,56 EUR 0,60%

2.947,70 INR 50,25 INR 1,73%

Indizes

6.836,8 PKT 62,1 PKT 0,92%

Aflac Incorporated AFL recently took a strategic step toward modernizing insurance distribution by partnering with Ethos to provide its supplemental health products through a fully digital platform. The partnership debuts with Aflac’s cancer insurance, which is now offered alongside Ethos’ life insurance options, allowing consumers to secure extra financial protection in just minutes.The partnership brings together Aflac’s deep-rooted knowledge in supplemental health insurance and Ethos’ innovative tech-driven distribution model. With Ethos’ platform, customers can easily access cancer coverage aimed at helping to ease the financial burden of out-of-pocket expenses related to diagnosis, treatment and recovery.A key feature of these policies is that they provide cash benefits directly to policyholders, offering flexibility to cover both medical and non-medical expenses associated with treatment. Plus, the inclusion of preventive screening benefits further enhances the product’s appeal by offering value even before a diagnosis is made and continues to support individuals throughout their care journey.For Aflac, this tie-up opens a new digital channel to reach customers who increasingly prefer fast, low-friction insurance purchases. Ethos’ digital-first approach allows AFL to push past traditional limits while maintaining product quality and straightforward claims. Plus, this collaboration aligns with Aflac’s ongoing “One Digital Aflac” initiative, which aims to leverage technology to improve customer experiences, streamline operations and boost sales productivity.Strategically, the Ethos tie-up positions Aflac to accelerate product innovation and better cross-selling opportunities in both life and supplemental health markets. As digital platforms increasingly become a primary access point, Aflac's proactive and organized approach could lead to steady premium growth and a stronger competitive edge.AFL’s Stock Price PerformanceOver the past year, Aflac’s shares have risen 7.5% compared with the industry’s growth of 7.8%.Image Source: Zacks Investment ResearchAFL’s Zacks Rank & Key PicksAFL currently carries a Zacks Rank #3 (Hold).Some top-ranked stocks in the broader finance space are LendingClub Corporation LC, Heritage Insurance Holdings Inc. HRTG and The Allstate Corporation ALL, each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for LendingClub’s current-year earnings of $1.15 per share has witnessed four upward revisions in the past 60 days against none in the opposite direction. LendingClub beat earnings estimates in three of the trailing four quarters and met once, with the average surprise being 38.3%. The consensus estimate for current-year revenues is pegged at $994.5 million, implying 26.4% year-over-year growth.The Zacks Consensus Estimate for Heritage Insurance’s current-year earnings of $5.14 per share has witnessed two upward revisions in the past 60 days against no movement in the opposite direction. Heritage Insurance beat earnings estimates in each of the trailing four quarters, with the average surprise being 100.1%. The consensus estimate for current-year revenues is pegged at $844.6 million, calling for 3.4% year-over-year growth.The Zacks Consensus Estimate for Allstate’s current-year earnings is pegged at $28.21 per share and has witnessed three upward revisions in the past 30 days against no movement in the opposite direction. Allstate beat earnings estimates in each of the trailing four quarters, with the average surprise being 47.3%. The consensus estimate for current-year revenues is pegged at $69 billion, calling for 7.2% year-over-year growth.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aflac Incorporated (AFL): Free Stock Analysis Report The Allstate Corporation (ALL): Free Stock Analysis Report LendingClub Corporation (LC): Free Stock Analysis Report Heritage Insurance Holdings, Inc. (HRTG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Aflac und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Aflac

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Aflac

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Aflac Inc

Wer­bung

Analysen zu Aflac Inc

DatumRatingAnalyst
21.03.2018Aflac Equal WeightBarclays Capital
03.07.2017Aflac Equal WeightBarclays Capital
01.05.2017Aflac UnderperformRBC Capital Markets
02.02.2017Aflac UnderperformRBC Capital Markets
09.12.2016Aflac UnderperformRBC Capital Markets
DatumRatingAnalyst
16.05.2012Aflac outperformRBC Capital Markets
14.05.2012Aflac overweightBarclays Capital
27.04.2012Aflac sector outperformScotia Capital Markets
26.04.2012Aflac outperformRBC Capital Markets
27.03.2012Aflac overweightBarclays Capital
DatumRatingAnalyst
21.03.2018Aflac Equal WeightBarclays Capital
03.07.2017Aflac Equal WeightBarclays Capital
10.05.2016Aflac Mkt PerformFBR Capital
27.04.2016Aflac NeutralUBS AG
27.04.2016Aflac Sector PerformRBC Capital Markets
DatumRatingAnalyst
01.05.2017Aflac UnderperformRBC Capital Markets
02.02.2017Aflac UnderperformRBC Capital Markets
09.12.2016Aflac UnderperformRBC Capital Markets
09.01.2012Aflac sellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Aflac Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen